Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Neil M Iyenger

25PUBLICATIONS
186CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsEnvironmental epidemiologyExercise physiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

Sort by Publication Date:
|Jul 10, 2026
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|Jul 09, 2026
Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk.

|Jun 30, 2026
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio‑Oncology Society (IC‑OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 29, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 28, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 05, 2026
Benralizumab relieves Eosinophil-Related Cutaneous Adverse Events from Cancer Therapy: A Nonrandomized Phase 2 Trial.

Pageof 5

Frequent Collaborators

4 joint publications

Sherry Shen

4 joint publications

Alexandre Chan

4 joint publications

Michelle B Nadler

4 joint publications

Jose Alvarez-Cardona

4 joint publications

Susan Dent

4 joint publications

Mridula George

4 joint publications

Anne Blaes

4 joint publications

Eng-Siew Koh

4 joint publications

Xi Kathy Zhou

4 joint publications

Ahamed Iqbal

Frequent Collaborators

4 joint publications

Sherry Shen

4 joint publications

Alexandre Chan

4 joint publications

Michelle B Nadler

4 joint publications

Jose Alvarez-Cardona